Phase I

Participants:
20–100 healthy volunteers

Purpose:

• Safety
• Dose determination

Phase II

Participants:
100–300 patients

Purpose:

• Preliminary effectiveness
• Safety

Phase III

Participants:
Large populations

Purpose:

• Confirm efficacy
• Support regulatory submission

Phase IV

Conducted after approval.

Purpose:

• Long-term monitoring